Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial.

Archibald, D W; Hebert, C A; Sun, D; Tacket, C O

Archibald, D W; Hebert, C A; Sun, D; Tacket, C O.

Affiliation

Archibald DW; Department of Oral Pathology, Dental School, University of Maryland, Baltimore 21201.

J Acquir Immune Defic Syndr (1988) ; 3(10): 954-8, 1990.

Article in En | MEDLINE | ID: mdl-2204698

Subject(s)

HIV Antibodies/biosynthesis; HIV-1/immunology; Immunoglobulin A, Secretory/biosynthesis; Saliva/immunology; Viral Vaccines/immunology; Blotting, Western; Double-Blind Method; Drug Evaluation; Gene Products, env/immunology; HIV Antibodies/blood; HIV Envelope Protein gp160; Humans; Protein Precursors/immunology; Recombinant Proteins/immunology; Vaccines, Synthetic/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Saliva / Immunoglobulin A, Secretory / Viral Vaccines / HIV Antibodies / HIV-1 Type of study: Clinical_trials Limits: Humans Language: En Journal: J Acquir Immune Defic Syndr (1988) Journal subject: DOENCAS SEXUALMENTE TRANSMISSIVEIS / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1990 Type: Article

Search on Google

XML

PubMed Links